Mode
Text Size
Log in / Sign up

Gluteus maximus morphology shows sex-specific associations with type 2 diabetes risk in UK Biobank imagingCould the shape of your glute muscle signal diabetes risk?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: GM morphology shows sex-specific T2D associations in imaging study; clinical relevance unclear.

This observational study analyzed UK Biobank imaging data to investigate associations between gluteus maximus (GM) muscle morphology and cardiometabolic factors, including type 2 diabetes (T2D). The study integrated conventional volumetric and fat fraction measurements with 3D shape quantification, examining how these features relate to age, adiposity, physical activity, and disease status in a population-based cohort. Sample size, specific interventions or exposures, and comparator groups were not reported.

Key findings included associations between GM morphology and multiple factors. GM volume and fat fraction were strongly associated with age, adiposity, and physical activity. Regional surface shrinkage was linked to age, BMI, alcohol intake, grip strength, physical activity, frailty, osteoporosis, and cardiometabolic disease. Regarding T2D, the study found sex-specific morphological patterns: regional shrinkage in men and relative expansion in women with T2D.

For incident T2D risk, specific shape principal components showed associations. In men, PC6 in the left GM showed a hazard ratio (HR) per standard deviation of 0.81 (95% CI 0.70-0.95, FDR-adjusted p=0.038), and in the right GM, HR 0.76 (95% CI 0.65-0.88, p=0.002). In women, PC5 in the right GM showed HR 1.32 (95% CI 1.08-1.61, p=0.032). Mediation analyses suggested T2D-related morphological differences partly mediated increases in fat fraction.

Safety and tolerability data were not reported as this was an imaging study without therapeutic intervention. The study's observational nature means reported associations do not establish causation. The authors propose that integrated 3D quantification of GM composition and morphology provides spatially resolved biomarkers that offer more nuanced muscle-fat phenotyping than volume or fat fraction alone, potentially enhancing mechanistic insight and risk stratification in population imaging. However, clinical applicability remains uncertain without validation and prospective studies.

What if a simple scan of a major muscle could reveal clues about your future health? A study using UK Biobank imaging data looked beyond simple muscle size and fat content to analyze the detailed 3D shape of the gluteus maximus—the body's largest muscle. They found that certain patterns of regional shrinkage or expansion in this muscle were associated with a person's likelihood of later developing type 2 diabetes.

The research showed these shape differences were linked to many factors we already connect with health, like age, body weight, physical activity levels, and grip strength. For men, a particular shape pattern in the left and right glute muscles was tied to a lower risk of developing diabetes. For women, a different shape pattern in the right glute was tied to a higher risk.

It's crucial to understand what this study is and isn't. This was an observational analysis, meaning it can only show a link or association between muscle shape and disease risk; it cannot prove that one causes the other. The researchers suggest that diabetes-related effects might work by changing the muscle's shape in specific areas, which then relates to how much fat builds up within it. This offers a more detailed way to look at muscle health in big population studies, but it's a long way from being a usable test in a doctor's office.

What this means for you:
Glute muscle shape is linked to diabetes risk in a large study, but this is an early observation, not a diagnostic tool.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background: The gluteus maximus (GM) is a major hip extensor essential for mobility and metabolic health. Most MRI studies rely on global measures, such as muscle volume or fat fraction, which can overlook spatially localised remodelling. Here, we integrate conventional volumetric and fat fraction metrics with 3D mesh-based shape phenotypes to provide a spatially resolved characterisation of GM morphology in relation to anthropometric, lifestyle, and cardiometabolic factors, with a focus on type 2 diabetes (T2D) and sex-specific effects. Methods: We analysed T1 Dixon MRI from UK Biobank participants to quantify GM muscle volume, fat fraction, and regional surface morphology using 3D meshes. Statistical parametric mapping was used to assess regional associations with anthropometric, lifestyle, and clinical variables Bi-directional causal mediation analyses were performed using GM volumetric and principal components (PCs) of shape variation. PCs were also tested for associations with prevalent and incident disease. Longitudinal changes in GM composition were evaluated in participants with repeated imaging evaluations. Results: GM muscle volume and fat fraction were strongly associated with age, adiposity, and physical activity. Shape analysis revealed spatially localised remodelling patterns not captured by global measures, with region-specific surface shrinkage linked to age, BMI, alcohol intake, grip strength, physical activity, frailty, osteoporosis, and cardiometabolic disease. T2D showed marked sex-differences, with regional shrinkage in men and relative expansion in women. PCA reduced high-dimensional shape variation into interpretable components. Mediation analyses indicated that T2D-related differences in GM morphology partly mediated increases in fat fraction, suggesting that disease effects manifest through spatially patterned shape changes rather than overall muscle size. PCs capturing variations in the central-upper posterior and anterior GM, differentiated between T2D cases from controls, and were associated with incident T2D risk (Men: PC6 HR per SD: 0.81 [0.70-0.95], false discovery rate (FDR)-adjusted p = 0.038, in left GM; 0.76 [0.65-0.88], p = 0.002, in right GM; women; PC5 HR = 1.32, [1.08-1.61], p = 0.032, in right GM). Conclusions: Integrated 3D quantification of GM composition and morphology provides spatially resolved biomarkers that go beyond muscle volume and fat fraction. By capturing region-specific GM remodelling, linked to anthropometric, lifestyle and cardiometabolic factors, this approach offers a more nuanced characterisation of muscle-fat phenotypes and enhances mechanistic insight and risk stratification in population-based imaging studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.